Literature DB >> 7739728

Extracellular proteolytic activity of Cryptococcus neoformans.

S Aoki1, S Ito-Kuwa, K Nakamura, J Kato, K Ninomiya, V Vidotto.   

Abstract

Eight strains of Cryptococcus neoformans var. neoformans isolated from AIDS patients in the Infectious Disease Institute, University of Turin, Italy, were examined for growth and extracellular proteolytic activity in culture with solid and liquid media. All of the strains grew well on Yeast Carbon Base (YCB) agar medium supplemented with both 0.1% (w/v) bovine serum albumin (BSA) and 0.01% (w/v) polypeptone (Pp), and produced a clear proteolytic zone around their colonies, whereas they exhibited less growth and proteolytic activity on YCB medium supplemented with BSA alone. Strain #8 with a strong proteolytic activity was cultured in three different liquid media. Its growth was limited in YCB medium supplemented with 0.1% BSA, but was moderate in that with 0.01% Pp. Enhanced growth was supported by the addition of both BSA and Pp to the YCB medium. The relative value of the final cellular yields obtained with the above YCB-0.1% BSA, YCB-0.01% Pp and YCB-0.1% BSA-0.01% Pp media was approximately 1:10:20. In the culture with YCB medium containing both BSA and Pp, a rapid decrease in the amount of BSA was demonstrated by a spectrophotometric assay and gel electrophoresis of the culture supernatant after the log-to-stationary phase. The proteolytic activity in the culture supernatant became detectable after the log phase when tested with skim milk agarose plates. These results allowed us to conclude that Cr. neoformans var. neoformans is able to secrete protease and to utilize protein as a source of nitrogen.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7739728     DOI: 10.1007/bf01138475

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

Review 1.  Fungal infections in AIDS patients.

Authors:  B Dupont; J R Graybill; D Armstrong; R Laroche; J E Touzé; L J Wheat
Journal:  J Med Vet Mycol       Date:  1992

Review 2.  Candida acid proteinases.

Authors:  R Rüchel; F de Bernardis; T L Ray; P A Sullivan; G T Cole
Journal:  J Med Vet Mycol       Date:  1992

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Detection of proteases by clotting of casein after gel electrophoresis.

Authors:  B Foltmann; P B Szecsi; N I Tarasova
Journal:  Anal Biochem       Date:  1985-05-01       Impact factor: 3.365

5.  Pigment production by Cryptococcus neoformans from para- and ortho-Diphenols: effect of the nitrogen source.

Authors:  S Chaskes; R L Tyndall
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

6.  Extracellular protease from the antarctic yeast Candida humicola.

Authors:  M K Ray; K U Devi; G S Kumar; S Shivaji
Journal:  Appl Environ Microbiol       Date:  1992-06       Impact factor: 4.792

7.  A variety of Candida proteinases and their possible targets of proteolytic attack in the host.

Authors:  R Rüchel
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1984-07

8.  Proteolytic activity of a clinical isolate of Cryptococcus neoformans.

Authors:  C H Brueske
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  Melanogenesis in Cryptococcus neoformans.

Authors:  I Polacheck; K J Kwon-Chung
Journal:  J Gen Microbiol       Date:  1988-04

10.  A comparison of secretory proteinases from different strains of Candida albicans.

Authors:  R Rüchel; R Tegeler; M Trost
Journal:  Sabouraudia       Date:  1982-09
View more
  19 in total

1.  Purification and characterization of a 43-kilodalton extracellular serine proteinase from Cryptococcus neoformans.

Authors:  Jae il Yoo Ji; Yeong Seon Lee; Chul-Yong Song; Bong Su Kim
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens.

Authors:  Vishnu Chaturvedi; Jean-Philippe Bouchara; Ferry Hagen; Ana Alastruey-Izquierdo; Hamid Badali; Anamelia Lorenzetti Bocca; Jose F Cano-Lira; Cunwei Cao; Sudha Chaturvedi; Sanjay H Chotirmall; Anne D van Diepeningen; Jean-Pierre Gangneux; Jesus Guinea; Sybren de Hoog; Macit Ilkit; Rui Kano; Weida Liu; Nilce M Martinez-Rossi; Marcia de Souza Carvalho Melhem; Mario Augusto Ono; Yuping Ran; Stephane Ranque; Celia Maria de Almeida Soares; Takashi Sugita; Philip A Thomas; Anna Vecchiarelli; Nancy L Wengenack; Patrick C Y Woo; Jianping Xu; Rosely M Zancope-Oliveira
Journal:  Mycopathologia       Date:  2018-11-30       Impact factor: 2.574

3.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases.

Authors:  Mahmoud Rouabhia; Martin Schaller; Cristina Corbucci; Anna Vecchiarelli; Stephan K-H Prill; Luc Giasson; Joachim F Ernst
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Extracellular proteinase activity of Cryptococcus neoformans.

Authors:  L C Chen; E S Blank; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

6.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

Review 7.  Virulence factors of medically important fungi.

Authors:  L H Hogan; B S Klein; S M Levitz
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

8.  Cryptococcus neoformans gene expression during experimental cryptococcal meningitis.

Authors:  B R Steen; S Zuyderduyn; D L Toffaletti; M Marra; S J M Jones; J R Perfect; J Kronstad
Journal:  Eukaryot Cell       Date:  2003-12

9.  Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage.

Authors:  Reginaldo dos Santos Pedroso; Joseane Cristina Ferreira; Marco Aurélio Sicchiroli Lavrador; Claudia Maria Leite Maffei; Regina Celia Candido
Journal:  Mycopathologia       Date:  2009-04-11       Impact factor: 2.574

10.  An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo.

Authors:  Anna Rachini; Donatella Pietrella; Patrizia Lupo; Antonella Torosantucci; Paola Chiani; Carla Bromuro; Carla Proietti; Francesco Bistoni; Antonio Cassone; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.